scholarly article | Q13442814 |
P356 | DOI | 10.3988/JCN.2010.6.2.89 |
P8608 | Fatcat ID | release_ddurzrzumbeelapgrnpk4kft7e |
P932 | PMC publication ID | 2895229 |
P698 | PubMed publication ID | 20607048 |
P5875 | ResearchGate publication ID | 45097995 |
P50 | author | Jae-Kyu Roh | Q12590440 |
Chang-Ho Yun | Q47503070 | ||
Ki-Hwan Ji | Q64859217 | ||
Soon-Tae Lee | Q79665386 | ||
Kon Chu | Q86742155 | ||
Keun-Hwa Jung | Q86742164 | ||
Sang Kun Lee | Q86742178 | ||
Kwon-Hee Park | Q96103904 | ||
P2093 | author name string | So-Hyun Kim | |
Hwan-Cheol Kim | |||
P2860 | cites work | Atherosclerosis | Q24644573 |
A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale | Q28256570 | ||
Circulating endothelial progenitor cells and cardiovascular outcomes | Q28271167 | ||
The occurrence of sleep-disordered breathing among middle-aged adults | Q29547889 | ||
Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies | Q29614505 | ||
Surgical treatment of obstructive sleep apnea: upper airway and maxillomandibular surgery | Q33318185 | ||
Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea | Q33748662 | ||
Sleep apnea and cardiovascular disease: an American Heart Association/american College Of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Counc | Q34013511 | ||
To drink or not to drink? That is the question | Q34685579 | ||
Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease | Q36519690 | ||
Diagnostic and therapeutic approach to nonsleepy apnea | Q36790467 | ||
Assessing identity, phenotype, and fate of endothelial progenitor cells | Q37231424 | ||
Circulating endothelial progenitor cells as a new marker of endothelial dysfunction or repair in acute stroke | Q39275184 | ||
Circulating endothelial progenitor cells, vascular function, and cardiovascular risk | Q39513285 | ||
Endothelial function and circulating endothelial progenitor cells in patients with sleep apnea syndrome | Q40166547 | ||
Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis | Q40646486 | ||
Circulating endothelial cells and endothelial progenitor cells in obstructive sleep apnea | Q40728292 | ||
Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. | Q43808880 | ||
Type 1 and type 2 diabetic patients display different patterns of cellular microparticles | Q44114915 | ||
Statin decreases endothelial microparticle release from human coronary artery endothelial cells: implication for the Rho-kinase pathway | Q44944931 | ||
Brief secondhand smoke exposure depresses endothelial progenitor cells activity and endothelial function: sustained vascular injury and blunted nitric oxide production | Q46083601 | ||
Effects of continuous positive airway pressure on cardiovascular risk profile in patients with severe obstructive sleep apnea and metabolic syndrome | Q46484855 | ||
Insulin resistance and daytime sleepiness in patients with sleep apnoea. | Q46555375 | ||
Predictors of blood pressure fall with continuous positive airway pressure (CPAP) treatment of obstructive sleep apnoea (OSA). | Q46664744 | ||
Circulating endothelial microparticle levels predict hemodynamic severity of pulmonary hypertension | Q46836578 | ||
Continuous positive airway pressure does not reduce blood pressure in nonsleepy hypertensive OSA patients | Q47644015 | ||
Prevalence of sleep-disordered breathing in middle-aged Korean men and women | Q47931759 | ||
Effects of nasal continuous positive airway pressure treatment on oxidative stress and adiponectin levels in obese patients with obstructive sleep apnea | Q48395056 | ||
Circulating endothelial microparticle levels and hemodynamic severity of pulmonary hypertension: is there a role for sleep apnea? | Q48410048 | ||
Circulating cell-derived microparticles in patients with minimally symptomatic obstructive sleep apnoea | Q48416885 | ||
Nasal continuous positive airway pressure treatment reduces systemic oxidative stress in patients with severe obstructive sleep apnea syndrome | Q48448711 | ||
Endothelial cell apoptosis in obstructive sleep apnea: a link to endothelial dysfunction | Q48478550 | ||
Predictors of elevated nuclear factor-kappaB-dependent genes in obstructive sleep apnea syndrome | Q48495147 | ||
Increased carotid intima-media thickness and serum inflammatory markers in obstructive sleep apnea | Q48538212 | ||
Endothelial Function in Obstructive Sleep Apnea and Response to Treatment | Q48616765 | ||
Adhesion molecules in patients with coronary artery disease and moderate-to-severe obstructive sleep apnea | Q48662343 | ||
Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness. a randomized, controlled trial | Q48692215 | ||
Effects of nasal continuous positive airway pressure on soluble cell adhesion molecules in patients with obstructive sleep apnea syndrome | Q48710576 | ||
Increased levels of circulating ICAM-1, VCAM-1, and L-selectin in obstructive sleep apnea syndrome | Q48753031 | ||
Circulating endothelial microparticles as a marker of cerebrovascular disease. | Q53497260 | ||
Decreased number and function of endothelial progenitor cells in patients with migraine | Q53545576 | ||
Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction | Q57589498 | ||
Increased Ratio of CD31 + /CD42 − Microparticles to Endothelial Progenitors as a Novel Marker of Atherosclerosis in Hypercholesterolemia | Q58419259 | ||
Measuring circulating cell-derived microparticles | Q62977671 | ||
High levels of circulating endothelial microparticles in patients with acute coronary syndromes | Q73502484 | ||
Effects of severe hypertension on endothelial and platelet microparticles | Q78945402 | ||
Endothelial microparticles and platelet and leukocyte activation in patients with the metabolic syndrome | Q79753554 | ||
Procoagulant membrane microparticles correlate with the severity of pulmonary arterial hypertension | Q79843837 | ||
Circulating microparticles in renal diseases | Q80722701 | ||
Obstructive sleep apnea: implications for cardiac and vascular disease | Q80824469 | ||
Endothelial microparticles affect angiogenesis in vitro: role of oxidative stress | Q81724759 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 2 | |
P921 | main subject | endothelium | Q111140 |
atherosclerosis | Q12252367 | ||
P304 | page(s) | 89-98 | |
P577 | publication date | 2010-06-30 | |
P1433 | published in | Journal of clinical neurology | Q26841853 |
P1476 | title | Increased circulating endothelial microparticles and carotid atherosclerosis in obstructive sleep apnea | |
P478 | volume | 6 |
Q41625778 | Absolute quantification of microparticles by flow cytometry in ascites of patients with decompensated cirrhosis: a cohort study |
Q37093990 | Altered profile of circulating endothelial progenitor cells in obstructive sleep apnea. |
Q63976693 | An Oral Glucose Load Decreases Postprandial Extracellular Vesicles in Obese Adults with and without Prediabetes |
Q48280242 | Applicability of extracellular vesicles in clinical studies. |
Q92090998 | Cardiovascular morbidities of obstructive sleep apnea and the role of circulating extracellular vesicles |
Q47682555 | Carotid Artery Wall Thickness in Obese and Nonobese Adults With Obstructive Sleep Apnea Before and Following Positive Airway Pressure Treatment |
Q43472325 | Circulating CD31+/Annexin V+ microparticles correlate with cardiovascular outcomes |
Q34259709 | Circulating CD62E+ microparticles and cardiovascular outcomes |
Q39413926 | Circulating exosomes in obstructive sleep apnea as phenotypic biomarkers and mechanistic messengers of end-organ morbidity |
Q30754485 | Circulating levels of cell-derived microparticles are reduced by mild hypobaric hypoxia: data from a randomised controlled trial |
Q58694951 | Current Treatment of Comorbid Insomnia and Obstructive Sleep Apnea With CBTI and PAP-Therapy: A Systematic Review |
Q47769927 | Diurnal variation of circulating microvesicles is associated with the severity of obstructive sleep apnoea |
Q58579190 | Endothelial Extracellular Vesicles in Pulmonary Function and Disease |
Q50072140 | Endothelial cell-derived microvesicles: potential mediators and biomarkers of pathologic processes. |
Q37863567 | Endothelial mechanisms of endothelial dysfunction in patients with obstructive sleep apnea |
Q28386977 | Endothelial microparticles in mild chronic obstructive pulmonary disease and emphysema. The Multi-Ethnic Study of Atherosclerosis Chronic Obstructive Pulmonary Disease study |
Q88888819 | Endothelial microvesicles in hypoxic hypoxia diseases |
Q27022210 | Evolving Role of Microparticles in the Pathophysiology of Endothelial Dysfunction |
Q33756578 | Exosomal miRNAs as potential biomarkers of cardiovascular risk in children |
Q56358143 | Extracellular Vesicles: A Novel Target for Exercise-Mediated Reductions in Type 2 Diabetes and Cardiovascular Disease Risk |
Q44277484 | Gender differences in the effect of comorbid insomnia symptom on depression, anxiety, fatigue, and daytime sleepiness in patients with obstructive sleep apnea |
Q34849981 | Increased Circulating Endothelial Apoptotic Microparticle to Endothelial Progenitor Cell Ratio Is Associated with Subsequent Decline in Glomerular Filtration Rate in Hypertensive Patients |
Q51007446 | Inflammatory responses to acute elevations of carbon dioxide in mice |
Q43107021 | Localized Cortical Thinning in Patients with Obstructive Sleep Apnea Syndrome |
Q92192989 | Mass Spectrometry Based Comparative Proteomics Using One Dimensional and Two Dimensional SDS-PAGE of Rat Atria Induced with Obstructive Sleep Apnea |
Q34026858 | Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles |
Q90134590 | Microparticle and interleukin-1β production with human simulated compressed air diving |
Q38032036 | Microparticles as Regulators of Cardiovascular Inflammation |
Q48305166 | Nocturnal release of leukocyte-derived microparticles in males with obstructive sleep apnoea |
Q37245483 | Obstructive sleep apnea and endothelial progenitor cells |
Q35410946 | Obstructive sleep apnea: an emerging risk factor for atherosclerosis. |
Q34997560 | Patients with obstructive sleep apnea display increased carotid intima media: a meta-analysis |
Q36087909 | Potential role of adult stem cells in obstructive sleep apnea |
Q48218840 | Prediction of Optimal CPAP Pressure and Validation of an Equation for Asian Patients With Obstructive Sleep Apnea |
Q41700530 | Procoagulant and platelet-derived microvesicle absolute counts determined by flow cytometry correlates with a measurement of their functional capacity |
Q35936364 | Regional Cerebral Blood Flow during Wakeful Rest in Older Subjects with Mild to Severe Obstructive Sleep Apnea |
Q28076751 | Role of sleep quality in the metabolic syndrome |
Q38019948 | Significance of endothelial dysfunction in sleep‐related breathing disorder |
Q55026575 | Sleep Disturbances as a Risk Factor for Stroke. |
Q28078600 | Stem/progenitor cells and obstructive sleep apnea syndrome - new insights for clinical applications |
Q47904324 | Sustained apnea induces endothelial activation. |
Q38942672 | The Association Between Obstructive Sleep Apnea and Carotid Intima-Media Thickness: A Systematic Review and Meta-Analysis |
Q35421591 | The utility of three screening questionnaires for obstructive sleep apnea in a sleep clinic setting |
Search more.